US Patent Issued to Nalu Bio on May 26 for "Cannabinol analogs and their use as pharmacologically active agents" (American, Canadian Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,296, issued on May 26, was assigned to Nalu Bio Inc. (San Francisco).

"Cannabinol analogs and their use as pharmacologically active agents" was invented by Mehdi Haghdoost (Stittsville, Canada), Caitlyn Krebs (San Francisco), Grazia Piizzi (Brookline, Mass.) and Phyllis Whiteley (Los Gatos, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are novel cannabinol (CBN) analogs, each exhibiting a difference in the level and/or type of interaction with the CB1 receptor as compared with the CB2 receptor, and, as such, provide for a significant reduction in psychoactive effects relative to CBN per se. Also provided are pharmaceutical fo...